Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cryopak Announces Agreement to Extend 40% of the Convertible Loan Agreement.


VANCOUVER, British Columbia -- Cryopak Industries Inc. (TSX TSX Toronto Stock Exchange (TSE before April, 2002)
TSX Transfer from Stack Pointer to Index
TSX True Space Extension
 VENTURE:CII CII Confederation of Indian Industry
CII Chartered Insurance Institute (UK)
CII Construction Industry Institute (University of Texas)
CII Council of Institutional Investors
) today announced that it has reached an agreement with the holders of 40% of the Company's outstanding $3.6 million convertible loan agreement (CLA CLA,
n.pr See acid, conjugated linoleic.
) to amend and restate the CLA.

Under the terms of the amended CLA, interest, which had been accumulating at 10% per annum Per annum

Yearly.
, has been forgiven, and 2.53% interest added to the outstanding principal. The principal will be repayable in equal instalments every six months beginning December 31, 2006. A reduced interest rate of LIBOR LIBOR

See: London Interbank Offered Rate


LIBOR

See London interbank offered rate (LIBOR).
 plus 25 basis points will be paid on the outstanding principal during this period. The amended CLA is no longer convertible into common shares of the Company.

This offer has also been made to the remaining holders with an interest in the CLA and the Company is in discussions with representatives for certain of those parties at this time.

About Cryopak

With facilities in Vancouver and Montreal, we are a leading provider of temperature-controlling products and solutions. Our clients include some of North America's leading retailers and consumer goods consumer goods

Any tangible commodity purchased by households to satisfy their wants and needs. Consumer goods may be durable or nondurable. Durable goods (e.g., autos, furniture, and appliances) have a significant life span, often defined as three years or more, and
 companies, as well as global pharmaceutical companies. In our retail business, we develop, manufacture and sell reusable ice substitutes, flexible hot and cold compresses, reusable gel ice and instant hot and cold packs. These products are marketed under such popular brand names as Ice-Pak(TM), Flexible Ice(TM) Blanket, Simply Cozy(R), and Flex Pak(TM). In our pharmaceutical business, we engineer solutions and supply products that help our customers safely transport their temperature sensitive pharmaceuticals. Over the past few years we have evolved into a recognized player in this growing segment as we assist customers in optimizing their cold chain processes. Our shares are listed on the TSX Venture Exchange TSX Venture Exchange

Originally called the Canadian Venture Exchange (CDNX), this was a result of the merger of the Vancouver and Alberta stock exchanges. The goal of TSX Venture Exchange is to provide venture companies with effective access to capital while protecting investors.
 under the symbol CII. For more information about our Company, please visit our website address at: www.cryopak.com or call 1.800.667.2532.

ON BEHALF OF THE BOARD OF DIRECTORS

Martin Carsky, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  

Certain statements contained herein are "forward-looking" statements (as such term is defined in the Private Securities Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ from those expressed or implied by such forward-looking statements.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Cryopak Industries Inc. (TSX VENTURE:CII)
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 19, 2005
Words:391
Previous Article:ADERANT Announces New Client Relationship Management System 'Purpose Built' for Professional Services Organizations at 2005 Marketing Partner Forum.
Next Article:Ahura Corporation Raises $10M B-Round to Accelerate Homeland Security Product Offerings.



Related Articles
Cryopak Announces Joint Venture with BioLargo Technologies Inc.; Products Approved For Strict New Blood Shipment Regulations.
Cryopak Builds Business with Aventis Pasteur Limited; Successful Completion of Testing Leads to Products & Services Partnership.
Cryopak Announces Senior Management Changes and Negotiations Concerning Convertible Loan.
Cryopak Releases FY2003 Results and Restatement of FY2003 Quarterly Results.
Cryopak Announces FY2004 First Quarter Results.
Cryopak Announces Offer To Amend Convertible Loan Agreement.
Cryopak Industries Inc.: Cryopak Announces 2004 Second Quarter Results.
Cryopak Announces Completion of $1.65 Million Private Placement.
Cryopak Announces Third Quarter 2004 Results, Strengthens Board of Directors, and Engages Investor Relations Advisors.
Cryopak Announces Second Closing of Private Placement.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles